Business
Press Release Aug 13 2021
Cadila Healthcare Limited has informed the Exchange regarding a press release dated August 13, 2021, titled "Zydus Cadila receives final approval from USFDA for Mesalamine Extended-Release Capsules".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Cadila Healthcare Limited has informed the Exchange regarding a press release dated August 13, 2021, titled \"Zydus Cadila receives final approval from USFDA for Mesalamine Extended-Release Capsules\". View Attachment","length":352,"tagName":"div"}]